Esperion Therapeutics, Inc.·4

Nov 30, 5:18 PM ET

Bartram Richard 4

4 · Esperion Therapeutics, Inc. · Filed Nov 30, 2018

Insider Transaction Report

Form 4
Period: 2018-11-28
Bartram Richard
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-11-28+12,00012,000 total
    Exercise: $52.38Exp: 2028-11-28Common Stock (12,000 underlying)
Footnotes (1)
  • [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on February 28, 2019.

Documents

2 files